Physician profile
Sharath Vipparthy
NPI 1588005078
$114,215.39
in general payments reported to CMS, 2019-2025
21 companies · $22K in 2025
The $22K reported for 2025 was more than what 89% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,131 · 2020: $2,216 · 2021: $21K · 2022: $44K · 2023: $14K · 2024: $10K · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $30K · Food and Beverage: $15K · Education: $68.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $30,440.60 |
| Food and Beverage | $15,020.62 |
| Education | $68.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $52,516.25 | 2021-2025 | Micra, Selectsecure, Claria Mri Quad Crt-D Surescan |
| Boston Scientific Corporation | $23,205.82 | 2020-2025 | General - Therapies, Watchman Access System, Watchman |
| Abbott Laboratories | $18,644.14 | 2019-2025 | Ensite, Ensite Precision, Aveir |
| Biotronik INC. | $11,457.78 | 2021-2025 | Acticor 7 Vr-T Dx, Solia, Sentus |
| Medical Device Business Services, INC. | $2,536.98 | 2022-2023 | Carto 3 |
| Medtronic Vascular, INC. | $1,292.04 | 2019-2020 | |
| Cardiofocus, INC. | $967.73 | 2022-2024 | Heartlight System |
| Abiomed | $883.03 | 2020-2021 | |
| Biosense Webster, INC. | $688.99 | 2021-2025 | Carto 3, Qdot Micro Catheter, Nuvision Ice Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $451.38 | 2020-2025 | Lifevest |
| Baylis Medical Company INC | $399.54 | 2021 | |
| Philips North America LLC | $351.42 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $338.28 | 2019 | |
| Cook Incorporated | $140.85 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.96 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $62.54 | 2019 | |
| Novo Nordisk INC | $48.88 | 2025 | Ozempic |
| Cook Medical LLC | $45.00 | 2019 | |
| Pfizer INC. | $32.08 | 2023-2025 | |
| Getinge USA Sales, LLC | $16.33 | 2021 | |
| Cvrx, INC. | $11.37 | 2024 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharath Vipparthy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.